Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06578104 · ClinicalTrials.gov registry record
PULSED AF Post-Approval Study
A clinical trial of Atrial Fibrillation, sponsored by Medtronic Cardiac Ablation Solutions.
- Recruiting
- Registry status
- 580
- Enrollment target
- 16
- Study locations
NCT06578104: Recruiting study of Atrial Fibrillation, sponsored by Medtronic Cardiac Ablation Solutions.
NCT06578104 is a study of Atrial Fibrillation that is actively recruiting participants, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 580 participants, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (81% lower). The trial reports 16 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06578104, a study of Atrial Fibrillation, is actively recruiting participants, sponsored by Medtronic Cardiac Ablation Solutions.
- RECRUITING
- Registry status
- 580 participants
- Enrollment target
- 16
- Study locations
Study Summary
PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.
Primary Outcome
Estimate the 36-month freedom from AF/AFL/AT recurrence following ablation using the PulseSelect™ PFA system.
Conditions Studied
Interventions
- DEVICE PulseSelect™ PFA system
Study Locations (16)
Ohio
- Bethesda North Hospital - Cincinnati
- The Ohio State University Wexner Medical Center - Columbus
- Mount Carmel Grove City Medical Center - Grove City
New York
- The Valley Hospital - New York
- Northwell Health Lenox Hill Hospital - New York
South Carolina
- AnMed Health Center - Anderson
- Medical University of South Carolina (MUSC) - Charleston
Florida
- University of South Florida Health (USF) - Tampa
Kentucky
- Pikeville Medical Center - Whitesburg
Massachusetts
- Southcoast Health System - Fall River
Michigan
- Beaumont Health System - Royal Oak
Nebraska
- Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 580 participants |
| Start Date | 2024-11-04 |
| Est. Completion | 2029-06-01 |
What NCT06578104 shows while recruiting
NCT06578104 is an observational study that tracks outcomes without assigning an intervention. The registered 580 participants enrollment target is mid-sized for trials with a published cap, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which PulseSelect™ PFA system is the first listed.
NCT06578104 lists 16 locations in 12 states (Ohio, New York, South Carolina).
Frequently Asked Questions
What is clinical trial NCT06578104 about?
NCT06578104 is a clinical study titled "PULSED AF Post-Approval Study". PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.
What is the current status of trial NCT06578104?
This trial is currently recruiting. The enrollment target is 580 participants. The study started on 2024-11-04. Estimated completion is 2029-06-01.
What conditions does trial NCT06578104 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT06578104?
The interventions under investigation include: PulseSelect™ PFA system (DEVICE).
Who is sponsoring clinical trial NCT06578104?
This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06578104 being conducted?
This trial has 16 study locations across Florida, Kentucky, Massachusetts, Michigan, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06578104's enrollment target sits among peer trials
580 55th of 202 higher than 148 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04575935 · 580 participants · Phase 3
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- NCT05143177 · 580 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
- NCT05696353 · 580 participants · Phase 3
Teen Driving Translation Study (NIH)
- NCT06647303 · 580 participants · NA
Improving Surgical Communication for Patients in Wisconsin
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI